RMD
RESMED INC CDI 10:1 FOR. EXEMPTResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
RMD
RMD
RESMED INC CDI 10:1 FOR. EXEMPT
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 0.49% | — |
| 24 Aug | 0.48% | — |
| 21 Aug | 0.46% | — |
| 20 Aug | 0.44% | — |
| 19 Aug | 0.43% | — |
| 18 Aug | 0.50% | — |
| 17 Aug | 0.53% | — |
| 14 Aug | 0.52% | — |
| 13 Aug | 0.49% | — |
Resmed INC CDI 10:1 For. Exempt (RMD) Short Interest Summary
Resmed INC CDI 10:1 For. Exempt (RMD) currently has 0.49% of its shares sold short (2.9 million shares, worth approximately $95.8 million), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes RMD the #312 most shorted stock on the ASX most shorted list. Short interest in RMD is down 0.00% over the past week and up 0.14% over the past month. RMD is part of the Health Care sector on the ASX.
Recent RMD Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 0.49% | 2.9M | $32.51 |
| 24 Aug 2026 | 0.48% | 2.8M | $31.96 |
| 21 Aug 2026 | 0.46% | 2.7M | $31.94 |
| 20 Aug 2026 | 0.44% | 2.6M | $32.13 |
| 19 Aug 2026 | 0.43% | 2.5M | $31.25 |
| 18 Aug 2026 | 0.50% | 2.9M | $31.04 |
| 17 Aug 2026 | 0.53% | 3.2M | $31.56 |
| 14 Aug 2026 | 0.52% | 3.1M | $31.96 |
| 13 Aug 2026 | 0.49% | 2.9M | $31.73 |
| 12 Aug 2026 | 0.45% | 2.7M | $31.38 |
RMD Short Selling — Frequently Asked Questions
What is Resmed INC CDI 10:1 For. Exempt (RMD)'s current short interest?
Resmed INC CDI 10:1 For. Exempt (RMD) currently has a short interest of 0.49% of total shares outstanding. This means 0.49% of RMD's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is RMD heavily shorted on the ASX?
RMD has a relatively low short interest of 0.49%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for RMD investors?
Short interest in RMD shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.49%, RMD's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this RMD short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for RMD.